P688: Performing NGS testing for myeloid malignancies in an academic medical center improves turnaround time and cost
Main Authors: | Christopher Giauque, Giovanni Insuasti-Beltran, Jordan Bouldin, Callie Barker, Randall Brunson, Lynne Rosenblum |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Genetics in Medicine Open |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2949774424007386 |
Similar Items
-
688 Transcriptome analyses in patients with myeloid malignances treated with the IRAK4 inhibitor emavusertib
by: Daniel J DeAngelo, et al.
Published: (2023-11-01) -
P100: BCR/ABL1 p230 transcript in B-lymphoblastic leukemia/lymphoma: A case report
by: Agshin Taghiyev, et al.
Published: (2024-01-01) -
Application of Newly Customized Myeloid NGS Panel in the Diagnosis of Myeloid Malignancies
by: Alkhatabi HA, et al.
Published: (2024-01-01) -
Turnaround leadership /
by: Fullan, Michael 428119
Published: (2006) -
Turnaround management /
by: 204207 Lenahan, Tom
Published: (1999)